152 related articles for article (PubMed ID: 35074476)
1. Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective.
Moctezuma-Velazquez C; Castro-Narro G; Simó P; Viayna E; Aceituno S; Soler M; Torre A
Ann Hepatol; 2022; 27(2):100673. PubMed ID: 35074476
[TBL] [Abstract][Full Text] [Related]
2. ALBUMIN VERSUS STANDARD MEDICAL TREATMENT IN BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS.
Terra C; Viayna E; Ayzin L; Fuster C; Aceituno S; Tafla C
Arq Gastroenterol; 2023; 60(3):356-363. PubMed ID: 37792766
[TBL] [Abstract][Full Text] [Related]
3. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; Piano S; Elia C; Prestianni L; Cappa FM; Cesarini L; Simone L; Pasquale C; Cavallin M; Andrealli A; Fidone F; Ruggeri M; Roncadori A; Baldassarre M; Tufoni M; Zaccherini G; Bernardi M;
Lancet; 2018 Jun; 391(10138):2417-2429. PubMed ID: 29861076
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
[TBL] [Abstract][Full Text] [Related]
5. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
Caraceni P; Tufoni M; Zaccherini G; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Simone L; Svegliati-Baroni G; Fagiuoli S; Laffi G; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Gasbarrini A; De Marco R; Piano S; Nardelli S; Elia C; Roncadori A; Baldassarre M; Bernardi M;
J Hepatol; 2021 Feb; 74(2):340-349. PubMed ID: 32853747
[TBL] [Abstract][Full Text] [Related]
6. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
7. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
[TBL] [Abstract][Full Text] [Related]
8. Albumin: Indications in chronic liver disease.
Tufoni M; Zaccherini G; Caraceni P; Bernardi M
United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
[TBL] [Abstract][Full Text] [Related]
9. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
10. Long-term albumin treatment in patients with cirrhosis and ascites.
Caraceni P; O'Brien A; Gines P
J Hepatol; 2022 Jun; 76(6):1306-1317. PubMed ID: 35589252
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Awal S; Yadav J; Awal L; Davis B; Kashiouris MG; Cable CA
Ann Hepatol; 2021 Dec; 26():100547. PubMed ID: 34626828
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
[TBL] [Abstract][Full Text] [Related]
13. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis.
Macken L; Bremner S; Gage H; Touray M; Williams P; Crook D; Mason L; Lambert D; Evans CJ; Cooper M; Timeyin J; Steer S; Austin M; Parnell N; Thomson SJ; Sheridan D; Wright M; Isaacs P; Hashim A; Verma S
Aliment Pharmacol Ther; 2020 Jul; 52(1):107-122. PubMed ID: 32478917
[TBL] [Abstract][Full Text] [Related]
15. Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
Torp N; Israelsen M; Coenraad M; Papp M; Shawcross D; Korenjak M; Angeli P; Laleman W; Juanola A; Gines P; Trebicka J; Krag A;
BMJ Open; 2024 Feb; 14(2):e079309. PubMed ID: 38355195
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
17. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial.
Macken L; Mason L; Evans C; Gage H; Jordan J; Austin M; Parnell N; Cooper M; Steer S; Boles J; Bremner S; Lambert D; Crook D; Earl G; Timeyin J; Verma S
Trials; 2018 Jul; 19(1):401. PubMed ID: 30053891
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
[TBL] [Abstract][Full Text] [Related]
20. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
Bernardi M; Caraceni P; Navickis RJ
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
[No Abstract] [Full Text] [Related]
[Next] [New Search]